- About us
- Clinical trials
- News & Publications
Robyn Hunter has over 30 years of financial management and capital market experience, previously having served first as vice president of finance and corporate controller, and later as chief financial officer of Fortress Biotech, where she oversaw the listing of four separate biotechnology companies on the Nasdaq Exchange. Her career in biotech began as corporate controller for Indevus Pharmaceuticals where she reengineered the financial and accounting operations for the $80 million company.
Robyn Hunter also serves on the board of Tenax Therapeutics, where she serves as the audit committee chair. She graduated with a Bachelor of Arts in Economics from Union College in Schenectady, New York. Robyn joined SOTIO in 2022 as Chief Financial Officer.